Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9

Here, we characterized the first French NDM-9-producing Acinetobacter baumannii isolate. A. baumannii 13A297, which belonged to the STPas25 (international clone IC7), was highly resistant to β-lactams including cefiderocol (MIC >32 mg/L). Whole genome sequencing (WGS) using both Illumina and...

Full description

Bibliographic Details
Published in:	Frontiers in Microbiology
Main Authors:	Susie Gaillot, Saoussen Oueslati, Jean-Baptiste Vuillemenot, Maxime Bour, Bogdan I. Iorga, Pauline Triponney, Patrick Plésiat, Rémy A. Bonnin, Thierry Naas, Katy Jeannot, Anaïs Potron
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Subjects:	Acinetobacter baumannii cefiderocol carbapenemases NDM resistance
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2023.1253160/full

Similar Items

Performance of the Disc Diffusion Method, MTS Gradient Tests and Two Commercially Available Microdilution Tests for the Determination of Cefiderocol Susceptibility in <i>Acinetobacter</i> spp.
by: Katy Jeannot, et al.
Published: (2023-07-01)

RESIST ACINETO test for the rapid detection of NDM and OXA acquired carbapenemases directly from blood culture in Acinetobacter species
by: Anaïs Potron, et al.
Published: (2024-10-01)

Uncommon close genetic environment responsible for weak expression of blaNDM-1 in Klebsiella pneumoniae of ST147
by: Delphine Girlich, et al.
Published: (2023-03-01)

Clonal Dissemination of NDM-Producing <em>Proteus mirabilis</em> in a Teaching Hospital in Sousse, Tunisia
by: Nadia Jaidane, et al.
Published: (2025-03-01)

Should we, and how to, optimize cefiderocol administration during severe nosocomial pneumonia due to carbapenem-resistant Acinetobacter baumanii? A viewpoint
by: Julien Massol, et al.
Published: (2024-09-01)

Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France
by: Agnès B. Jousset, et al.
Published: (2023-09-01)

Comparison of Two Lateral Flow Immunochromatographic Assays for Rapid Detection of KPC, NDM, IMP, VIM and OXA-48 Carbapenemases in Gram-Negatives
by: Clara Morales Dominguez, et al.
Published: (2025-09-01)

To Be or Not to Be an OXA-48 Carbapenemase
by: Laura Dabos, et al.
Published: (2022-01-01)

Multiple host colonization and differential expansion of multidrug-resistant ST25-Acinetobacter baumannii clades
by: Agnese Lupo, et al.
Published: (2023-12-01)

Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak
by: Giovanna Travi, et al.
Published: (2024-08-01)

Beta-lactamase database (BLDB) – structure and function
by: Thierry Naas, et al.
Published: (2017-01-01)

Comment on Mitteregger et al. A Variant Carbapenem Inactivation Method (CIM) for <i>Acinetobacter baumannii</i> Group with Shortened Time-to-Result: rCIM-A. <i>Pathogens</i> 2022, <i>11</i>, 482
by: Andrei-Alexandru Muntean, et al.
Published: (2022-07-01)

Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131.
by: Rémy A Bonnin, et al.
Published: (2012-01-01)

β-Lactamase Genes without Limits
by: Thierry Naas, et al.
Published: (2023-05-01)

The occurrence of the carbapenemase gene, blaNDM-5, on a transmissible IncX3 plasmid in multidrug-resistant Escherichia coli isolated from a farm dog
by: Dina Daaboul, et al.
Published: (2024-03-01)

Molecular, Genetic, and Biochemical Characterization of OXA-484 Carbapenemase, a Difficult-to-Detect R214G Variant of OXA-181
by: Camille Gonzalez, et al.
Published: (2024-07-01)

Retrospective and prospective evaluation of the Carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae.
by: Lauraine Gauthier, et al.
Published: (2017-01-01)

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium
by: Saoussen Oueslati, et al.
Published: (2022-10-01)

MacAB-TolC Contributes to the Development of Acinetobacter baumannii Biofilm at the Solid–Liquid Interface
by: Brandon Robin, et al.
Published: (2022-01-01)

Commercially available tests for determining cefiderocol susceptibility display variable performance in the Achromobacter genus
by: Vincent Jean-Pierre, et al.
Published: (2024-08-01)

Emergence of cefiderocol resistance during therapy in NDM-5–producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations
by: Luc Deroche, et al.
Published: (2025-02-01)

Cefiderocol in the Successful Treatment of Complicated Hospital-Acquired K. pneumoniae NDM, OXA48 Intraabdominal Infection
by: Tarski I, et al.
Published: (2024-11-01)

In Vitro Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirA
by: Christi L. McElheny, et al.
Published: (2021-12-01)

Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia
by: Mohamed H. Al-Agamy, et al.
Published: (2016-01-01)

Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains
by: Vincent Jean-Pierre, et al.
Published: (2024-06-01)

Adaptation to cinnamaldehyde shapes Pseudomonas aeruginosa resistance to major antibiotics
by: Eline Dubois, et al.
Published: (2025-10-01)

Activity of cefiderocol against NDM-producing <i>Enterobacterales</i> from a regional outbreak in the Tuscany region, Italy
by: A. Bartolini, et al.
Published: (2023-04-01)

Emergence of blaNDM-9-bearing tigecycline-resistant Klebsiella aerogenes of chicken origin
by: Yan Li, et al.
Published: (2021-09-01)

Adaptive resistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB): microbiological and clinical issues
by: Anissa Desmoulin, et al.
Published: (2024-05-01)

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
by: Keith S. Kaye, et al.
Published: (2023-02-01)

Validation of Three MicroScan<sup>®</sup> Antimicrobial Susceptibility Testing Plates Designed for Low-Resource Settings
by: Jean-Baptiste Ronat, et al.
Published: (2022-08-01)

Evaluation of the EasyScreen™ ESBL/CPO Detection Kit for the Detection of ß-Lactam Resistance Genes
by: Camille Gonzalez, et al.
Published: (2022-09-01)

Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing
by: Souheil Zayet, et al.
Published: (2022-11-01)

Genomic characterization of plasmids harboring blaNDM-1, blaNDM-5, and blaNDM-7 carbapenemase alleles in clinical Klebsiella pneumoniae in Pakistan
by: Muhammad Usman Qamar, et al.
Published: (2025-07-01)

In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
by: Rémy A. Bonnin, et al.
Published: (2023-01-01)

Nationwide molecular epidemiology of carbapenemase-producing Citrobacter spp. in France in 2019 and 2020
by: Laura Biez, et al.
Published: (2023-12-01)

Emergence of New Non–Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Isolates, France
by: Rémy A. Bonnin, et al.
Published: (2020-06-01)

Metallo-Beta-Lactamases: NDM
by: Kamil Leis, et al.
Published: (2019-05-01)

Emergence of Neonatal Sepsis Caused by MCR-9- and NDM-1-Co-Producing Enterobacter hormaechei in China
by: Chunlei Chen, et al.
Published: (2022-05-01)

Diversity of mucoid to non-mucoid switch among carbapenemase-producing Klebsiella pneumoniae
by: Adriana Chiarelli, et al.
Published: (2020-10-01)